News Pfizer promotes potential CEO successor Bourla Move could allow CEO Read to focus on mega-merger.
News Ex-GSK chiefs Witty and Slaoui join biotech investors Former GSK CEO Sir Andrew Witty, and his former drug development chief, Moncef Slaoui have both lined up new jobs as life science investors.
News Teva appoints Lundbeck's Kare Schultz as CEO Unlike AZ's Soriot, Schultz "couldn't refuse" top job at Teva.
News AZ CEO set to take charge at Teva - report Report raises concerns about outcome of MYSTIC trial.
News After missing out on CEO job, Novo's US head quits The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
